Heart & Cardiometabolic HealthGlucose Monitoring & Safety

Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency Care

Hypoglycaemia (< 70mg/dL blood sugar) is a potentially life threatening acute endocrine emergency often seen in patients on insulin or sulfonylureas. This article will discuss the neuroendocrine effects of decreasing blood sugar, the difference between autonomic and neuroglycopenic symptoms, the standardised clinical approach known as The Rule of 15 and emergency glucagon rescue.

Published: 2026-08-25Reviewed: October 2026Updated: 2026-11-03T12:14:46.167Z 10 min read 4590 Views
Listen to this guide Audio Edition

Hands-free audio narration

Educational Health Notice

This educational guide is researched in accordance with our Editorial Policy and public health guidelines. It is not personal medical advice. For clinical questions, read our Medical Disclaimer or consult a qualified healthcare provider.

Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency Care

Quick Summary & Key Findings

Hypoglycaemia is when blood glucose levels fall below 70mg/dL (Level 1) or 54mg/dL (Level 2) or if assistance is required (Level 3). Mild-moderate hypoglycaemia can be treated using the rule of 15. That is, consume a fast acting carbohydrate source containing 15g. Wait 15 mins then test your blood glucose again. If still less than 70mg/dL repeat this process. If unconscious administer Glucagon immediately and call 112 (India) or 911 (US) or your local emergency number.

The most immediate acute risk in diabetes is hypoglycaemia. The human brain is completely dependent on glucose in the blood stream, using approximately 120g of glucose per day.

If blood glucose levels fall below normal levels, the body will respond rapidly with a neuroendocrine response. Insulin production will stop and glucagon, epinephrine, nor epinephrine, cortisol and growth hormone will be released in high amounts to cause glycogenolysis in the liver.

However, if frequent episodes of hypoglycaemia occur the body will become less responsive to the neuroendocrine response. This is known as Hypoglycemia-Associated Autonomic Failure (HAAF) or ‘hypoglycemia unawareness’. This can cause patients to become unaware of their hypoglycaemia until they become confused, seizuring or into a coma.

Clinical Classification & Neuroglycopenic Symptom Cascade

The American Diabetes Association (ADA) classifies hypoglycaemia into 3 levels: Level 1 Hypoglycaemia (Alert Value <70 mg/dL (<3.9mmol/L)). Autonomic symptoms occur, so immediate treatment with quick acting carbohydrate should be given. Level 2 Hypoglycaemia (Clinically significant <54mg/dL (<3.0mmol/L)). Neuroglycopenic symptoms begin. Glucose metabolism in the brain starts to be affected. Level 3 Hypoglycaemia (Severe). Severe neuroglycopenia occurs. Assistance is required from a third party to treat with carbohydrate/glucagon/intravenous dextrose.
Autonomic (Adrenergic) Symptoms: Tremors, diaphoresis (cold clammy sweats), tachycardia, palpitations, hunger, severe anxiety
Neuroglycopenic Symptoms: Confusion, blurred vision, slurred speech, ataxia (drunken-like gait), dizziness, behavioral agitation
Severe Consequences: Loss of consciousness, generalized tonic-clonic seizures, hypoglycemic coma, brain damage
Sulfonylureas (Glipizide, Glyburide) and exogenous Insulin are the primary pharmacological culprits

The Standardized Clinical 'Rule of 15' Protocol

Step NumberClinical ActionExact Dosage / Food ExampleKey Clinical Rationale
Step 1: Confirm GlucoseCheck capillary blood glucose via fingerstick or CGM.Blood glucose reading < 70 mg/dL.Confirms hypoglycemia before treating.
Step 2: Administer CarbsConsume exactly 15 grams of fast-acting pure carbohydrate.4 glucose tablets, 4 oz (1/2 cup) fruit juice, or 1/2 can regular soda.Pure simple sugars raise blood sugar within 10–15 minutes without fat delaying gastric emptying.
Step 3: Wait 15 MinutesSit quietly and wait 15 minutes; do not eat further.15-minute observation window.Allows intestinal absorption and prevents rebound hyperglycemia from overeating.
Step 4: Re-Test Blood SugarRe-check capillary fingerstick blood glucose.Target: Blood glucose > 70–80 mg/dL.Verifies whether glucose has safely risen above the alert threshold.
Step 5: Repeat or SnackIf still <70 mg/dL, repeat Step 2. If >70 mg/dL, eat a meal/snack with complex carbs & protein.Peanut butter with crackers or scheduled meal.Replenishes glycogen and stabilizes blood glucose for subsequent hours.

Emergency Glucagon Rescue for Severe (Level 3) Hypoglycemia

Do not give anything by mouth to an unconscious diabetic, having a seizure or who cannot safely swallow (risk of aspiration). Give emergency glucagon:
Nasal Glucagon Powder (Baqsimi) Dose ready to administer. Insert nozzle into one nostril and press down completely. Can be used when patient is unconscious or has a cold.
Auto-Injector Glucagon (Gvoke HypoPen, Zegalogue) Inject into the outer thigh, abdomen or upper arm by depressing the pre-filled subcutaneous auto-injector pen for between 5 and 10 seconds.
Traditional Glucagon Emergency Kit (GEK): Add diluent using the diluent syringe to reconstitute the sterile powder and administer by intramuscular injection into a large muscle group.
Call 112 (India) / 911 (US) or your local Emergency Services: It is important to call emergency medical services after giving a glucagon injection. Put the patient in recovery position (on their side). This is because they often vomit after being woken up by the glucagon.

When to Contact Your Diabetes Care Team

Schedule an urgent medication adjustment if:
  • You experience recurrent unexplained daytime or nocturnal hypoglycemia (>2 episodes in a single week)
  • You wake up with soaked nightclothes, morning headaches, or night terrors (signs of nocturnal hypoglycemia)
  • You no longer feel shaky or sweaty when your blood glucose drops below 60 mg/dL (Hypoglycemia Unawareness)
  • You require third-party glucagon administration or emergency room treatment

Whipple's Triad, The Counterregulatory Cascade & The Pathophysiology of HAAF

Hypoglycaemia is a serious medical condition where blood sugar levels drop below the required levels to provide energy for the central nervous system. As the brain cannot produce glucose and has very little glycogen stores, it relies heavily on a constant supply of glucose from the arteries. When glucose drops to low levels a well regulated homeostatic response occurs. This consists of: 1. Pancreatic beta cells stop producing insulin at around 80-85mg/dL. 2. Pancreatic alpha cells and adrenal glands produce glucagon and epinephrine respectively at around 65-70mg/dL. 3. Cortisol and growth hormone are released after a delay at around 60mg/dL.
Whipple's Triad: This is used to clinically diagnose true hypoglycaemia. 1. Symptoms of hypoglycaemia; 2. Plasma glucose concentrations are shown to be abnormally low at the time of symptoms; 3. Symptoms are relieved rapidly by giving glucose/carbohydrates.
ADA Clinical Classification of Hypoglycemia: Level 1 (fasting blood glucose between 54-70 mg/dL. Caution level for administration of fast acting carbohydrate) Level 2 (blood glucose <54mg/dL clinically significant neuroglycopenia and impaired cognition). Level 3 (Severe hypoglycaemia. Altered mental state, fitting and unconsciousness. Requires help to recover).
Hypoglycaemia-Associated Autonomic Failure (HAAF): Those with insulin treated diabetes who have had recent episodes of hypoglycaemia will have diminished sympatho-adrenal responses. This results in reduced thresholds for autonomic counter-regulatory symptoms (tremors, sweating, palpitations) meaning that symptoms are induced at very low blood glucose levels. This is known as hypoglycaemia unawareness.
Cardiac Arrhythmogenic Risk: severe hypoglycaemia causes prolonged corrected QT interval (QTc) on ECG plus hypokalaemia from intracellular potassium shift caused by epinephrine. This can cause fatal cardiac arrhythmias (dead-in-bed syndrome).

The Evidence-Based 'Rule of 15', Ready-to-Use Nasal Glucagon & Emergency Action

Managing hypoglycemia requires rapid standardized intervention to restore cerebral glucose delivery while avoiding over-treatment rebound hyperglycemia.
Clinical 'Rule of 15’ Protocol: If a conscious patient has a blood glucose level <70mg/dL, give them an exact amount of fast acting simple carbohydrate (4 glucose tablets, 4oz/120mL of fruit juice or 1 tablespoon of sugar or honey). Wait 15 minutes then check their capillary glucose again. If it is still <70mg/dL repeat giving another 15g until their blood glucose is back to normal.
Avoid high fat sweet treats like chocolate or whole milk as they contain fats that will cause a significant delay in gastric emptying and slow glucose absorption in the intestines causing prolonged cerebral neuroglycopenia.
Ready to use nasal glucagon (Baqsimi 3mg) – can be administered to patients who are unconscious or unable to take action during a level 3 hypoglycaemic emergency. The powdered glucagon is absorbed passively via the nasal mucosa. This will cause the liver to break down stored glycogen within 5-10 minutes.
Auto Injectors & Pre-Mixed Pens (Gvoke, Zegalogue) Ready to use liquid stable formulation of glucagon receptor agonists. Rapid subcutaneous rescue. Easy to use by family members and in workplace emergency kit. .

Continuous Glucose Monitor (CGM) Predictive Alerts & Exercise Management

Modern real-time Continuous Glucose Monitoring (rtCGM) devices are now revolutionising hypoglycaemia prevention using predictive algorithms to calculate the decline of interstitial glucose concentration. This provides a predictive alert system which gives patients an advance of 20-30 mins on the trend of their glucose levels. This allows patients to make small carbohydrate adjustments to prevent hypoglycaemia from occurring.
Predictive Low Glucose Alert Thresholds. Setting your Predictive alerts on your CGM to alert you when an impending low will occur (Glucose levels are predicted to fall below 80mg/dL in 20 minutes) means that a small amount of fast acting carbs (8-10g) can be consumed before neuroglycopenia occurs avoiding a rebound high.
Exercise-induced late nocturnal hypoglycaemia Physical activity increases insulin independent GLUT4 mediated glucose uptake. This is followed by several hours of increased insulin sensitivity and muscle glycogen repletion. Patients are at increased risk of severe nocturnal hypoglycaemia between 6 and 15 hours after exercise. Basal insulins should be reduced in advance of sleep (by up to 20%.)
Bedtime Glycemic Target Buffers: Patients who are experiencing recurrent nocturnal hypoglycemia or hypoglycemia unawareness should have their bedtime sensor glucose within a range of 100-140 mg/dL. A protein complex carbohydrate snack such as peanut butter on whole wheat if <100 mg/dL will provide this protection.
Mechanism of Alcohol induced Hypoglycaemia Ethanol undergoes metabolism in the liver by alcohol dehydrogenase, generating excess intracellular NADH. This causes hepatic gluconeogenesis to be inhibited. When consumed by a fasting individual or patient receiving insulin, alcohol can cause severe and resistant hypoglycaemia. Glucagon will not help as there is no hepatic glycogen available.

Frequently Asked Questions

S
Clinical Reviewer License Verified

Dr. Shikha Sharma, MBBS

Founder & Medical Director, NutriHealth Delhi NCR; Clinical Nutrition Lead • MBBS (Maulana Azad Medical College)
Medical Review Board

Dr. Shikha Sharma is an MBBS graduate from Maulana Azad Medical College (MAMC), New Delhi, and a pioneer in clinical nutrition, gut health, and preventive lifestyle medicine in Delhi NCR with over 25 years of medical consulting experience.

License ID: DMC-12490
Medical Director, NutriHealth Delhi NCR; Consulting Preventive Physician
Medically evaluated on October 2026View Dr. Profile, Verified Credentials & Articles

References & Clinical Resources

  1. Seaquist ER, Anderson J, Childs B, et al.. Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013). [Access Resource Link] — Diabetes Care. 36(5):1384-1395
  2. Cryer PE. Hypoglycemia-Associated Autonomic Failure in Diabetes Mellitus (2005). [Access Resource Link] — Physiological Reviews. 85(4):1141-1188
  3. Rickels MR, Ruedy KJ, promote NC, et al.. Efficacy of Nasal Glucagon for Resolving Insulin-Induced Hypoglycemia in Adults with Type 1 Diabetes (2016). [Access Resource Link] — Diabetes Care. 39(2):264-270
Article Tools & Sharing:
Educational Resources
Patient Community Doctor Reviewed

Reader Reviews & Clinical Q&A

Real experiences, reader questions, and verified physician guidance.

5.0 out of 5 (3 reviews)
AW
Arthur W., T2D AdvocateVerified Patient
•August 18, 2026

The biochemical explanation of glycemic variability and continuous monitoring metrics was eye-opening. Tracking my daily averages against the ADA targets in this article helped me lower my morning readings significantly.

Dr. Ambrish Mithal, MD, DM (Endocrinology)Endocrinologist & Clinical Specialist
August 19, 2026

Outstanding progress, Arthur! Consistent tracking of postprandial patterns and morning fasting numbers provides actionable feedback that transforms metabolic health.

ER
Evelyn R., CaregiverCaregiver
•August 29, 2026

I manage meals and appointments for my elderly mother with diabetes. The practical dietary recommendations and lab interpretation guide gave our family a clear, actionable roadmap.

Dr. Ambrish Mithal, MD, DM (Endocrinology)Endocrinologist & Clinical Specialist
August 30, 2026

Caregivers play an invaluable role in long-term glycemic stability, Evelyn. Balancing complex dietary carbs with proper hydration and regular screening makes a world of difference.

DB
Dr. Brenda M., Certified Diabetes EducatorClinical Specialist
•September 08, 2026

Thorough, scientifically accurate, and aligns perfectly with current ADA Standards of Care. The FAQ section addresses the exact concerns patients bring to education classes.

Dr. Ambrish Mithal, MD, DM (Endocrinology)Endocrinologist & Clinical Specialist
September 09, 2026

Thank you, Brenda! We make it a priority to update all endocrine and diabetes resources as soon as major professional societies update their consensus guidelines.

Leave a Review or Ask a Medical Question

5 / 5 Stars
* Reviews are reviewed by our clinical editorial team in accordance with our medical policies.